We are live on ! Find out more
PCP

Pacific Capital Partners Portfolio holdings

AUM $116M
1-Year Est. Return 24.59%
This Fund
S&P 500
This Quarter Est. Return
-6.37%
1 Year Est. Return
+24.59%
3 Year Est. Return
+49.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$170M
AUM Growth
-$678K
Cap. Flow
-$21.1M
Cap. Flow %
-12.39%
Top 10 Hldgs %
51.79%
Holding
57
New
3
Increased
17
Reduced
11
Closed
7

Top Buys

Rank Stock Value
1
KBR icon
KBR
KBR
+$6.38M
2
AVTR icon
Avantor
AVTR
+$4.5M
3
CNMD icon
CONMED
CNMD
+$3.83M
4
AMTM
Amentum Holdings
AMTM
+$3.23M
5
ACA icon
Arcosa
ACA
+$2.01M

Top Sells

Rank Stock Value
1
ICLR icon
Icon
ICLR
+$33.6M
2
BWXT icon
BWX Technologies
BWXT
+$5.19M
3
MOH icon
Molina Healthcare
MOH
+$4.31M
4
BLFS icon
BioLife Solutions
BLFS
+$1.82M
5
WWD icon
Woodward
WWD
+$1.28M

Sector Composition

Rank Sector Weight
1 Healthcare 46.16%
2 Industrials 26.99%
3 Financials 9.95%
4 Materials 6.12%
5 Consumer Discretionary 5.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
26
AbbVie
ABBV
$469B
$1.87M 1.1%
10,522
– –
TRU icon
27
TransUnion
TRU
$16B
$1.85M 1.09%
20,000
-10,000
-33% -$1.01M
LAB icon
28
Standard BioTools
LAB
$252M
$1.75M 1.03%
1,000,000
+175,000
+21% +$326K
SCI icon
29
Service Corp International
SCI
$11.3B
$1.72M 1.01%
21,522
-1,203
-5% -$98.4K
CG icon
30
Carlyle Group
CG
$17.2B
$1.62M 0.95%
32,074
-6,000
-16% -$304K
EXAS
31
DELISTED
Exact Sciences
EXAS
$1.6M 0.94%
28,500
– –
HOLX
32
DELISTED
Hologic
HOLX
$1.58M 0.93%
21,974
– –
MRK icon
33
Merck
MRK
$369B
$1.36M 0.8%
13,681
– –
LULU icon
34
lululemon athletica
LULU
$13B
$1.28M 0.75%
3,352
+1,196
+55% +$390K
STRA icon
35
Strategic Education
STRA
$1.84B
$1.27M 0.75%
13,606
+2,267
+20% +$212K
COO icon
36
Cooper Companies
COO
$14.9B
$1.18M 0.69%
12,838
– –
BSX icon
37
Boston Scientific
BSX
$73.5B
$1.18M 0.69%
13,156
– –
EPAM icon
38
EPAM Systems
EPAM
$5.52B
$1.17M 0.69%
5,000
– –
CVSA
39
Covista Inc
CVSA
$4.51B
$1.16M 0.68%
12,803
– –
BC icon
40
Brunswick
BC
$5.16B
$992K 0.58%
15,343
– –
PBH icon
41
Prestige Consumer Healthcare
PBH
$2.41B
$976K 0.57%
12,500
– –
LLY icon
42
Eli Lilly
LLY
$1.12T
$962K 0.57%
1,246
– –
NKE icon
43
Nike
NKE
$59.3B
$957K 0.56%
12,645
+4,673
+59% +$367K
FTRE icon
44
Fortrea Holdings
FTRE
$1.75B
$933K 0.55%
50,000
– –
HCA icon
45
HCA Healthcare
HCA
$88.1B
$749K 0.44%
2,495
– –
TMDX icon
46
Transmedics
TMDX
$3.22B
$748K 0.44%
12,000
+2,218
+23% +$206K
AMP icon
47
Ameriprise Financial
AMP
$49.4B
$730K 0.43%
1,372
-626
-31% -$334K
PRCT icon
48
Procept Biorobotics
PRCT
$1.25B
$666K 0.39%
8,269
-12,607
-60% -$1.08M
COLM icon
49
Columbia Sportswear
COLM
$3.06B
$639K 0.38%
7,609
-2,914
-28% -$244K
ECL icon
50
Ecolab
ECL
$79.6B
$622K 0.37%
2,653
– –
1
2
3

Similar funds

VWA
Vistica Wealth Advisors Carlsbad, California $116M AUM
JBC
Jefferson Bridge Capital Nashville, Tennessee $115M AUM
IIWM
Investment Insight Wealth Management North Massapequa, New York $115M AUM
JBI
John Boyer Inc Tampa, Florida $115M AUM 28.27% 1-Year Est. Return
BWM
Bluebird Wealth Management Medfield, Massachusetts $115M AUM
SAM
Stembrook Asset Management Red Bank, New Jersey $116M AUM
ACA
Alpha Capital Advisors Bangor, Maine $116M AUM
VFM
Vision Financial Markets Stamford, Connecticut $115M AUM 18.96% 1-Year Est. Return

Pacific Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Pacific Capital Partners held 57 positions worth $170M, down 0.4% from $171M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pacific Capital Partners withdrew a net $21.1M in Q4 2024, closing 7 positions and reducing 11 holdings. Its most notable exit was Molina Healthcare, an estimated $4.31M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 52% a quarter earlier, followed by Industrials and Financials.

Against the trend, Pacific Capital Partners opened a new position in KBR worth $5.79M.

  • Pacific Capital Partners's largest Q4 2024 buy was KBR: 100,000 shares worth $5.79M.
  • Pacific Capital Partners added most to Avantor in Q4 2024, an estimated $4.5M increase.
  • Pacific Capital Partners's biggest Q4 2024 reduction was Icon, cutting an estimated $33.6M.
  • Pacific Capital Partners fully exited Molina Healthcare in Q4 2024, selling an estimated $4.31M.
  • Pacific Capital Partners's ten largest holdings make up 52% of its $170M portfolio in Q4 2024.
  • Pacific Capital Partners opened 3 new positions and closed 7 in Q4 2024.
  • Pacific Capital Partners's portfolio value fell 0.4% quarter-over-quarter to $170M.

Based on Pacific Capital Partners's 13F filing for Q4 2024, filed 8 May 2025.